Nugene Intl Inc Financials
This page shows Nugene Intl Inc (NUGN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Livento’s reported balance-sheet strength masks a cash-thin operating model where sales and assets are not translating into day-to-day liquidity.
From FY2023 to FY2024, reported earnings improved faster than cash economics: net loss narrowed from-$6.5M to-$596K . But operating cash flow remained negative and gross margin worsened from-46.7% to-73.6% , showing the better bottom line did not come from healthier unit economics.
Scale sits on the balance sheet rather than in sales: FY2024 assets were
Working capital became the real funding bottleneck: receivables reached
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Nugene Intl Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Nugene Intl Inc has an operating margin of -9196.8%, meaning the company retains $-9197 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -127.5% the prior year.
Nugene Intl Inc's revenue declined 91% year-over-year, from $1.7M to $151K. This contraction results in a growth score of 0/100.
Nugene Intl Inc carries a low D/E ratio of 0.09, meaning only $0.09 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 4.00, Nugene Intl Inc holds $4.00 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 79/100.
Nugene Intl Inc converts 544.6% of revenue into free cash flow ($825K). This strong cash generation earns a score of 100/100.
Nugene Intl Inc generates a -27.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -1.4% the prior year.
Nugene Intl Inc passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Nugene Intl Inc generates $-0.07 in operating cash flow ($825K OCF vs -$12.3M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Nugene Intl Inc generated $151K in revenue in fiscal year 2025. This represents a decrease of 91.0% from the prior year.
Nugene Intl Inc reported -$12.3M in net income in fiscal year 2025. This represents a decrease of 1965.7% from the prior year.
Cash & Balance Sheet
Nugene Intl Inc generated $825K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 628.9% from the prior year.
Nugene Intl Inc held $4K in cash against $0 in long-term debt as of fiscal year 2025.
Nugene Intl Inc had 221,450 shares outstanding in fiscal year 2025. This represents a decrease of 100.0% from the prior year.
Margins & Returns
Nugene Intl Inc's gross margin was -1351.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1277.8 percentage points from the prior year.
Nugene Intl Inc's operating margin was -9196.8% in fiscal year 2025, reflecting core business profitability. This is down 9069.3 percentage points from the prior year.
Nugene Intl Inc's net profit margin was -8137.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 8102.5 percentage points from the prior year.
Nugene Intl Inc's ROE was -27.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 26.5 percentage points from the prior year.
Capital Allocation
Nugene Intl Inc invested $0 in capex in fiscal year 2025, funding long-term assets and infrastructure.
NUGN Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $125K | N/A | $329K+40.7% | $234K-25.1% | $313K+4.8% | $298K-43.5% | $528K-5.6% | $559K |
| Cost of Revenue | $610K | N/A | $772K+30.6% | $591K-25.5% | $794K-2.5% | $814K+6.0% | $768K+22.5% | $627K |
| Gross Profit | -$485K | N/A | -$442K-24.0% | -$357K+25.8% | -$481K+6.7% | -$516K-114.8% | -$240K-252.1% | -$68K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $71K | N/A | $47K | N/A | $68K | N/A | $4K | N/A |
| Operating Income | -$623K | N/A | -$581K-49.6% | -$388K+42.7% | -$678K+37.0% | -$1.1M-162.2% | -$410K-299.9% | -$103K |
| Interest Expense | $0 | N/A | $0 | $0 | $0 | N/A | $6K-19.6% | $8K |
| Income Tax | $0 | N/A | $0 | $0 | $0 | N/A | $0 | $0 |
| Net Income | -$379K | N/A | -$225K-252.8% | $147K+121.7% | -$678K+32.6% | -$1.0M-145.1% | -$410K-256.0% | $263K |
| EPS (Diluted) | N/A | N/A | N/A | $0.00 | N/A | N/A | N/A | $0.00 |
NUGN Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $47.7M-0.9% | $48.1M+8.0% | $44.5M-1.4% | $45.2M-2.3% | $46.2M-2.9% | $47.6M-0.8% | $48.0M-0.2% | $48.1M |
| Current Assets | $4.4M-5.2% | $4.6M+150.4% | $1.8M-8.2% | $2.0M-31.8% | $2.9M-14.1% | $3.4M+6.3% | $3.2M-0.2% | $3.2M |
| Cash & Equivalents | $16K+297.6% | $4K-62.6% | $11K-83.8% | $65K+164.5% | $25K+338.3% | $6K+113.1% | $3K-66.9% | $8K |
| Inventory | $0 | N/A | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $3.9M-4.8% | $4.1M+184.9% | $1.5M-14.7% | $1.7M-33.4% | $2.6M-14.9% | $3.0M+7.3% | $2.8M+0.8% | $2.8M |
| Goodwill | $0 | N/A | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3.8M-2.0% | $3.8M+37.6% | $2.8M-18.0% | $3.4M-11.9% | $3.9M-7.4% | $4.2M+2.1% | $4.1M-0.2% | $4.1M |
| Current Liabilities | $1.1M-4.3% | $1.2M+443.2% | $212K-37.8% | $340K-32.1% | $501K-26.6% | $683K+14.6% | $596K-1.5% | $605K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $43.9M-0.8% | $44.3M+6.1% | $41.7M-1.5% | $42.3M0.0% | $42.3M-2.1% | $43.3M-1.4% | $43.9M+0.4% | $43.7M |
| Retained Earnings | -$32.3M-1.2% | -$31.9M-51.1% | -$21.1M-3.7% | -$20.4M0.0% | -$20.4M-2.7% | -$19.8M-6.4% | -$18.7M-2.1% | -$18.3M |
NUGN Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $114K-58.2% | $273K+419.6% | $53K-89.7% | $508K+5739.7% | -$9K+97.1% | -$307K-208.8% | $282K+804.9% | -$40K |
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | $114K-58.2% | $273K+419.6% | $53K-89.7% | $508K+5739.7% | -$9K+97.1% | -$307K-208.8% | $282K+804.9% | -$40K |
| Investing Cash Flow | -$104K-115.9% | $653K+673.1% | -$114K+75.7% | -$468K-104.4% | -$229K-287.9% | $122K+128.7% | -$424K-8664.0% | $5K |
| Financing Cash Flow | $0+100.0% | -$930K-13922.1% | $7K+6631.0% | $100-100.0% | $259K+38.4% | $187K+36.6% | $137K+387.9% | $28K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0 |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NUGN Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -388.9% | N/A | -134.3%+18.1pp | -152.4%+1.4pp | -153.9%+19.0pp | -172.9%-127.4pp | -45.5%-33.3pp | -12.2% |
| Operating Margin | -499.5% | N/A | -176.3%-10.4pp | -165.8%+50.9pp | -216.7%+143.6pp | -360.3%-282.6pp | -77.7%-59.4pp | -18.4% |
| Net Margin | -303.9% | N/A | -68.3%-131.3pp | 62.9%+279.6pp | -216.7%+120.1pp | -336.8%-259.1pp | -77.7%-124.7pp | 47.0% |
| Return on Equity | -0.9% | N/A | -0.5%-0.9pp | 0.4%+1.9pp | -1.6%+0.7pp | -2.3%-1.4pp | -0.9%-1.5pp | 0.6% |
| Return on Assets | -0.8% | N/A | -0.5%-0.8pp | 0.3%+1.8pp | -1.5%+0.6pp | -2.1%-1.3pp | -0.9%-1.4pp | 0.5% |
| Current Ratio | 3.97-0.0 | 4.00-4.7 | 8.69+2.8 | 5.89+0.0 | 5.87+0.9 | 5.01-0.4 | 5.40+0.1 | 5.33 |
| Debt-to-Equity | 0.090.0 | 0.09+0.0 | 0.07-0.0 | 0.08-0.0 | 0.090.0 | 0.100.0 | 0.090.0 | 0.09 |
| FCF Margin | 91.4% | N/A | 15.9%-201.1pp | 217.1%+220.0pp | -2.9%+100.1pp | -103.0%-156.5pp | 53.5%+60.7pp | -7.2% |
Similar Companies
Frequently Asked Questions
What is Nugene Intl Inc's annual revenue?
Nugene Intl Inc (NUGN) reported $151K in total revenue for fiscal year 2025. This represents a -91.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nugene Intl Inc's revenue growing?
Nugene Intl Inc (NUGN) revenue declined by 91% year-over-year, from $1.7M to $151K in fiscal year 2025.
Is Nugene Intl Inc profitable?
No, Nugene Intl Inc (NUGN) reported a net income of -$12.3M in fiscal year 2025, with a net profit margin of -8137.7%.
What is Nugene Intl Inc's gross margin?
Nugene Intl Inc (NUGN) had a gross margin of -1351.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Nugene Intl Inc's operating margin?
Nugene Intl Inc (NUGN) had an operating margin of -9196.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Nugene Intl Inc's net profit margin?
Nugene Intl Inc (NUGN) had a net profit margin of -8137.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Nugene Intl Inc's return on equity (ROE)?
Nugene Intl Inc (NUGN) has a return on equity of -27.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Nugene Intl Inc's free cash flow?
Nugene Intl Inc (NUGN) generated $825K in free cash flow during fiscal year 2025. This represents a 628.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Nugene Intl Inc's operating cash flow?
Nugene Intl Inc (NUGN) generated $825K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Nugene Intl Inc's total assets?
Nugene Intl Inc (NUGN) had $48.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Nugene Intl Inc's capital expenditures?
Nugene Intl Inc (NUGN) invested $0 in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Nugene Intl Inc's current ratio?
Nugene Intl Inc (NUGN) had a current ratio of 4.00 as of fiscal year 2025, which is generally considered healthy.
What is Nugene Intl Inc's debt-to-equity ratio?
Nugene Intl Inc (NUGN) had a debt-to-equity ratio of 0.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Nugene Intl Inc's return on assets (ROA)?
Nugene Intl Inc (NUGN) had a return on assets of -25.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Nugene Intl Inc's Piotroski F-Score?
Nugene Intl Inc (NUGN) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nugene Intl Inc's earnings high quality?
Nugene Intl Inc (NUGN) has an earnings quality ratio of -0.07x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Nugene Intl Inc?
Nugene Intl Inc (NUGN) scores 46 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.